|
|
This [mergers and acquisitions consulting][1] service helps pharmaceutical companies make strategy-led business development and licensing decisions. It supports the full deal lifecycle — from identifying acquisition targets and screening partners to conducting commercial due diligence, shaping negotiation strategy and managing post-deal integration.
|
It is ok to contact this poster with commercial interests.
|